Designing Nanoparticles for Targeted Cancer Therapy

The aim of the program “Designing Nanoparticles for Targeted Cancer Therapy” is to provide participants with a comprehensive understanding of the principles, techniques, and advancements in designing nanoparticles specifically tailored for targeted cancer therapy.

• Explore Nanoparticle Design and Engineering
• Examine Drug Loading and Release Mechanisms
• Characterize Nanoparticle Properties
• Improve the Pharmacokinetics
• Reduce the Systemic Toxicities of Chemotherapies

• Undergraduate degree in Chemistry, Biology, Pharmacy, or related fields.
• Professionals in pharmaceuticals, biotechnology, or healthcare sectors.
• Individuals with a background in materials science or medicinal chemistry interested in oncology.

• Enhanced understanding of cancer biology, including the hallmarks of cancer and oncogenic signaling pathways.
• Familiarity with different cancer treatment modalities, such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy.
• Knowledge of the applications of nanotechnology in cancer therapy, particularly the advantages of nanoparticles in drug delivery, imaging, and theranostics.
• Awareness of drug resistance mechanisms in cancer and exploration of strategies to overcome or mitigate resistance through nanoparticle-based therapies.
• Understanding of tumor targeting strategies, including active targeting using ligands or antibodies, passive targeting via the enhanced permeability and retention (EPR) effect, and physicochemical targeting based on tumor-specific characteristics.